James E. Bradner is EVP, R&D, & Chief Sci. Officer of AMGEN INC. Currently has a direct ownership of 25,438 shares of AMGN, which is worth approximately $8.12 Million. The most recent transaction as insider was on May 07, 2024, when has been sold 2,863 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.4K
0% 3M change
n/a 12M change
Total Value Held $8.12 Million

James E. Bradner Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 07 2024
BUY
Grant, award, or other acquisition
-
2,863 Added 10.12%
25,438 Common Stock
Feb 09 2024
BUY
Grant, award, or other acquisition
-
22,393 Added 50.0%
22,393 Common Stock
JEB

James E. Bradner

EVP, R&D, & Chief Sci. Officer
Thousand Oaks, CA

Track Institutional and Insider Activities on AMGN

Follow AMGEN INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMGN shares.

Notify only if

Insider Trading

Get notified when an Amgen Inc insider buys or sells AMGN shares.

Notify only if

News

Receive news related to AMGEN INC

Track Activities on AMGN